Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug repurposing in the management of major depressive disorder: a perspective.

East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan·2026
Same author

Colored Light Exposure Ensues Chronotype-Based Responses: Evidence From QEEG Analysis.

Physiological research·2025
Same author

An International ASXL3 Natural History Study: Deep Phenotypic Analyses Including Detailed Reports of a Milder Phenotype, Novel Associations, and Clinical Recommendations.

American journal of medical genetics. Part A·2025
Same author

Revisiting venous drainage of dorsum of foot for anatomical rationale behind venous ulcers, a cadaveric study.

La Clinica terapeutica·2025
Same author

Dose to Organ at Risk and its Characteristic Variation with the Clinically Used Different Prescription Levels for Early-stage Left-sided Breast Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

Management of childhood MDR-TB in Europe and Central Asia: report of a Regional WHO meeting.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022

Related Experiment Video

Updated: Jul 7, 2026

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta
11:44

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta

Published on: September 27, 2017

Obesity and pregnancy.

A Dixit1, J C Girling

  • 1Maternal Medicine, Chelsea and Westminster and West Middlesex University Hospital, London, UK.

Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
|February 9, 2008
PubMed
Summary
This summary is machine-generated.

Obesity in pregnancy poses significant risks to both mothers and fetuses, including gestational diabetes and stillbirth. Preconception counseling and weight management are crucial for high-risk pregnancies.

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Swimming Exercise Protocol and Care Methods for Pregnant Rats
05:17

Swimming Exercise Protocol and Care Methods for Pregnant Rats

Published on: April 5, 2024

Related Experiment Videos

Last Updated: Jul 7, 2026

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta
11:44

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta

Published on: September 27, 2017

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Swimming Exercise Protocol and Care Methods for Pregnant Rats
05:17

Swimming Exercise Protocol and Care Methods for Pregnant Rats

Published on: April 5, 2024

Area of Science:

  • Reproductive health
  • Maternal-fetal medicine
  • Public health

Background:

  • Obesity is a growing global health concern, increasingly identified as a significant risk factor in pregnancy.
  • Managing obesity preconceptionally is vital for mitigating pregnancy-related complications.

Purpose of the Study:

  • To highlight the multifaceted risks associated with obesity during pregnancy.
  • To emphasize the need for preconception counseling and weight management strategies.
  • To advocate for the development of specific management guidelines for pregnant individuals with obesity.

Main Methods:

  • Literature review on maternal and fetal outcomes in obese pregnancies.
  • Analysis of risks including gestational diabetes, hypertension, pre-eclampsia, operative delivery, postpartum hemorrhage, and thromboembolic complications.
  • Examination of fetal risks such as miscarriage, neural-tube defects, macrosomia, and stillbirth.

Main Results:

  • Obesity significantly elevates maternal risks, including gestational diabetes, hypertension, pre-eclampsia, and increased operative delivery rates.
  • Fetal complications associated with maternal obesity encompass miscarriage, neural-tube defects, macrosomia, and stillbirth.
  • Bariatric surgery may be a consideration for some women prior to conception.

Conclusions:

  • Pregnancy in women with obesity presents a high-risk scenario requiring specialized obstetric care.
  • Preconception counseling and active weight management are essential for improving outcomes.
  • Obstetric units must implement robust guidelines for managing pregnancies affected by obesity.